SATURDAY, MAY 6, 2023
7:00 PM - 11:00 PM
SAN FIEGO, CALIFORNIA
THE 2022 HONOREES
2022 LIFETIME ACHIEVEMENT HONOREE
DR. ARLAN L. ROSENBLOOM
Arlan L. Rosenbloom is Distinguished Service Professor Emeritus of Pediatrics at the University of Florida College of Medicine (UFCOM) and Professor Emeritus at Universidad San Francisco de Quito, Ecuador. He graduated from University of Wisconsin (UW) in 1958 and went to a rotating internship at Los Angeles County General Hospital followed by a GP residency at Ventura County General Hospital. He then served with MEDICO in Cambodia and Malaysia, returning to UW for pediatric residency and endocrine fellowship. He was drafted in 1966 and spent two years in West Africa with the smallpox eradication program of CDC. At the UFCOM since 1968, he founded the Pediatric Endocrinology Division, Florida's Diabetes Camps, the UF Diabetes Research Education & Treatment Center, and the Regional Diabetes & Endocrine Program for Children, and directed the General Clinical Research Center. He has served on numerous editorial boards, and on review committees for FDA, NIH, and other US and international grant agencies. He has authored/co-authored 380 articles and 85 chapters or books, primarily on diabetes and growth. He has mentored ~30 fellows, most of whom have pursued academic careers. His awards include the Faculty Research Prize of the UFCOM in 1994, the Distinguished Medical Alumnus Citation of the Univ of Wisconsin in 1995, the Florida Blue Key Distinguished Faculty Award in 1995, the Distinguished Physician Award of The Endocrine Society for 2003, the ISPAD (International Society for Pediatric and Adolescent Diabetes) award for 2014, the University of Florida College of Medicine Lifetime Achievement Award for 2017, and the 2017 Van Wyk prize of the Pediatric Endocrine Society.
2022 VISIONARY HONOREE
DR. MEHUL DATTANI
Mehul Dattani is Professor of Paediatric Endocrinology based at the University College London (UCL) Great Ormond Street Institute of Child Health, and Specialty Lead in Endocrinology at Great Ormond Street Hospital for Children (GOSH). He has an active clinical practice in paediatric and adolescent Endocrinology at GOSH and University College London Hospitals (UCLH). He completed a 3-year term as Chair of the British Society for Paediatric Endocrinology and Diabetes, followed by a 7 year term as Chair of the Programme Organizing Committee and member of the Council of the European Society for Paediatric Endocrinology (ESPE). He is the Convenor/Host of the European Society for Paediatric Endocrinology for 2024, and hosted the ESPE2022 Online Annual meeting. He has also served as co-Chair of the Pituitary Main Thematic Group of the ENDO-ERN initiative until December 2020.
Professor Dattani has established a laboratory group investigating the molecular basis of hypothalamo-pituitary disease at UCL. He has identified novel genes implicated in hypothalamo-pituitary development in patients with congenital hypopituitarism, and has worked on understanding the molecular basis of a paediatric brain tumour called adamantinomatous craniopharyngioma. He has more than 250 publications including original articles and scholarly reviews in a number of high impact journals, as well as numerous book chapters. He sits on numerous advisory boards and editorial boards of journals. He has previously received the ESPE Henning Andersen and RCPCH Donald Paterson awards for his scientific work. He has co-authored 3 textbooks to date, including the 7th Edition of Brook’s Clinical Paediatric Endocrinology.
2022 DR. ROBERT BLIZZARD FOUNDER'S AWARD
DR. STEVE CHERNAUSEK
Steven Chernausek, MD is the CHF Edith Kinney Gaylord Professor of Pediatrics at the University of Oklahoma College of Medicine. He grew up in a small Minnesota town and graduated from Carleton College with a BA in biology. He received his MD degree from the University of Minnesota and did a residency in Pediatrics there as well. As a Pediatric Endocrine Fellow at the University of North Carolina at Chapel Hill, he was introduced to the insulin-like growth factors (IGFs) and the control of somatic growth by Louis Underwood and Judson Van Wyk. Following fellowship, he joined the faculty at Cincinnati Children’s Hospital Medical Center and continued studies of human growth, with a focus on the GH/IGF axis. While there he played a major role in the clinical trials leading to FDA approval of hGH for Turner S, short stature following SGA birth, and idiopathic short stature as well as rhIGF-I for primary IGF deficiency. In 2007 he joined the faculty at the University of Oklahoma Health Science Center and became the first Director of the CMRI Pediatric Metabolic Research Program.
His resume lists more than 150 publications and includes the first description of IGF resistance due to IGF receptor gene defects along with the results of clinical trials of rhIGF-I and rhGH in a variety of growth disorders, He has served on the editorial boards of Endocrinology and Journal of Clinical Endocrinology and Metabolism and was chair and medical editor of the Sub-board of Endocrinology of the American Board of Pediatrics. He is a member of the American Pediatric Society, served on the Council for the Society for Pediatric Research and is a past president of the Pediatric Endocrine Society. He now spends most of his time in Montana with Amy Wisniewski enjoying the outdoors, winter and summer.